Not applicableStudy completedNCT05025618What this trial is testingAdaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTOME)Who this might be right forOropharynx Cancer Center Eugene Marquis 132
Large-scale testing (Phase 3)Study completedNCT00002476What this trial is testingRadiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Cancer Research UK
Not applicableStudy completedNCT01194635What this trial is testingBiomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation TherapyWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 69
Not applicableLooking for participantsNCT06642324What this trial is testingHuman Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell CarcinomasWho this might be right forHead Neck CancerOropharyngeal Neoplasms Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 550
Not applicableLooking for participantsNCT07718620What this trial is testingHPV-associated Oropharyngeal Carcinoma (HPV-OPC)Who this might be right forOropharyngeal Carcinoma (OPC) Masaryk Memorial Cancer Institute 35
Testing effectiveness (Phase 2)Study completedNCT00003582What this trial is testingRadiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer University of Miami 36
Not applicableLooking for participantsNCT00898638What this trial is testingTissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT00494182What this trial is testingSorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell CancerWho this might be right forMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Squamous Cell Carcinoma of the HypopharynxMetastatic Squamous Cell Carcinoma of the Larynx+7 more M.D. Anderson Cancer Center 48
Early research (Phase 1)Active Not RecruitingNCT04533750What this trial is testingTesting the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+15 more National Cancer Institute (NCI) 21
Not applicableUnknownNCT05393297What this trial is testingInGReS: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation StudyWho this might be right forHead and Neck Cancer Guy's and St Thomas' NHS Foundation Trust 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03822897What this trial is testingDe-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell CarcinomaWho this might be right forOropharyngeal Cancer Canadian Cancer Trials Group 103
Early research (Phase 1)Study completedNCT02113878What this trial is testingPhase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NeckWho this might be right forCarcinoma, Squamous Cell of Head and NeckHPV Positive Oropharyngeal Squamous Cell CarcinomaHypopharyngeal Cancer+3 more Dana-Farber Cancer Institute 23
Not applicableLooking for participantsNCT06307015What this trial is testingDe-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)Who this might be right forHPV Positive Oropharyngeal Squamous Cell Carcinoma Royal North Shore Hospital 25
Not applicableStudy completedNCT01958515What this trial is testingImmunologic Responses in HPV-Associated Carcinoma for Patients Receiving ChemoradiationWho this might be right forHead and Neck CancerHPV (Human Papillomavirus)-Associated CarcinomaOropharyngeal Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Early research (Phase 1)Study completedNCT02381535What this trial is testingOnalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinWho this might be right forStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT04260126What this trial is testingStudy of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCCWho this might be right forMetastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more PDS Biotechnology Corp. 95
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04220749What this trial is testingRadiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell CarcinomaWho this might be right forHead and Neck CancerOropharyngeal Squamous Cell Carcinoma London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 68
Testing effectiveness (Phase 2)Study completedNCT00024089What this trial is testingGefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 60